Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Invested Capital (2021 - 2025)

Rxo's Invested Capital history spans 5 years, with the latest figure at $1.9 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 1.77% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, down 1.77%, while the annual FY2025 figure was $1.9 billion, 1.77% down from the prior year.
  • Invested Capital reached $1.9 billion in Q4 2025 per RXO's latest filing, down from $2.0 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $2.0 billion in Q3 2024 to a low of $949.0 million in Q1 2024.
  • Average Invested Capital over 5 years is $1.4 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Invested Capital: fell 12.93% in 2023, then skyrocketed 109.8% in 2025.
  • A 5-year view of Invested Capital shows it stood at $1.1 billion in 2021, then decreased by 2.62% to $1.0 billion in 2022, then fell by 8.54% to $953.0 million in 2023, then skyrocketed by 107.76% to $2.0 billion in 2024, then decreased by 1.77% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Invested Capital are $1.9 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025).